In addition, ACE2 has been proven to play a protective role in chronic lung injury, pulmonary fibrosis, and pulmonary vasoconstriction in other lung injury models, for example, bleomycin-induced pulmonary fibrosis models and monocrotaline-induced pulmonary hypertension models [34, 35]. Here, ACE2 is linked to pulmonary fibrosis.